Press Releases

Provepharm, a start-up specialized in the development of pharmaceutical applications, announces today that, following a one-year centralized review procedure, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CMPH) issued a favorable assessment of its methylthioninium chloride...

TxCell SA, a biotechnology company developing cell-based immuno-therapies for the treatment of severe chronic inflammatory diseases with high medical need, announced the appointment of Dr. François Meyer as its chief executive officer. “The appointment of François...

Oxford Medical Diagnostics (OMD), the UK developer of breath based, medical diagnostic technology for the rapid, non-invasive, accurate and low-cost diagnosis and monitoring of metabolic and infectious diseases; and V&F Analyse- und Messtechnik GmbH (V&F), a provider of analytical...

Nycomed’s US partner Forest Laboratories, Inc.announced that DalirespTM (roflumilast) was approved by the US Food and Drug Administration (FDA) as a treatment to reduce the risk of chronic obstructive pulmonary disease (COPD) exacerbations in patients with severe COPD associated...

PharmaDiagnostics NV, a company developing and marketing a broadly-enabling, label-free screening technology that uniquely does not require specialized instrumentation, announces today the appointment of Dr Sylviane Boucharens as director of assay development. Sylviane joins from Merck’s MSD site in...

Biocitech SAS, the Paris life science technology park, today announced that its 25 resident companies applied for a bumper number of patents with a nearly 70 per cent leap to 147 in 2010. This represents an almost five-fold increase...

Apricus Biosciences, Inc. announced that the European Patent Office will grant a patent for the company's MycoVa™ product for treating onychomycosis (commonly referred to as nail fungus). The European Patent Office recently issued a "notice of allowance" for the...